×

Sanofi weighs takeover of US drugmaker Insmed, Bloomberg News reports

By Thomson Reuters Nov 19, 2026 | 9:18 AM

Nov 19 (Reuters) – Sanofi is weighing an acquisition of US ​drugmaker Insmed, Bloomberg ‌News reported on Thursday, citing people familiar with the matter.

Shares of Insmed, ‌which ​has ⁠a market valuation ⁠of $26.28 billion according to LSEG data, were up 14%. Insmed did ​not immediately respond to a Reuters ⁠request for ⁠comment.

Sanofi said it ​does not comment on ​market rumors.

French drugmaker Sanofi ‌is speaking with advisers as it studies a potential deal ⁠for Insmed, Bloomberg reported, citing the people, who asked ⁠not ‌to be ⁠identified discussing confidential ​information.

Deliberations ‌are ongoing and ​any deal ⁠could still be weeks away, the report added.

(Reporting by Sneha S K; Editing by Maju ​Samuel)